Brochure - HealthCapital - Netzwerk Gesundheitswirtschaft Berlin ...

Brochure - HealthCapital - Netzwerk Gesundheitswirtschaft Berlin ...



Health as a Potentiality, Interview with Prof. Dr. Dr. h.c. Günter Stock .................................................................... 03

HealthCapital-Trademark of Berlin-Brandenburg ...................................................................................................... 06

Creating Products out of Knowledge ........................................................................................................................ 08

Guaranteeing Qualified Specialists for Tomorrow ..................................................................................................... 10

Identifying and Exploiting Growth Potential ............................................................................................................. 12

Internationally Attractive Location ............................................................................................................................. 14

Innovation Motor Biotechnology ................................................................................................................................ 16

From the Clinic into the Application ........................................................................................................................... 18

Berlin Model of Nursing Is a Nationwide Model ........................................................................................................ 20

Quality of Patient Care Is Our Top Priority ................................................................................................................. 22

Prevention Is the Best Therapy .................................................................................................................................... 24

Strengthening Clinical Research on Location ............................................................................................................. 26

Using the Developmental Potential of Health Locations .......................................................................................... 28

Know-How from Berlin-Brandenburg Is in Demand Worldwide .............................................................................. 30

Data and Facts about Health Economics in Berlin-Brandenburg .............................................................................. 32

Well Advised and Informed ......................................................................................................................................... 33

Health as a Potentiality

Interview with Professor Dr. Dr. h.c. Günter Stock, Cluster Spokesman and

Network Speaker of HealthCapital

Professor Stock, how do you

classify the health region of Berlin-

Brandenburg at the present time?

“We are one of Europe‘s leading

health regions. Our particular

strengths lie in the excellent

fundamental research, outstanding

clinical installations and – where

we particularly excel – the presence

of several pharmaceutical concerns

which actively carry on research

and development here. The regionally

present value chain in its

entirety is not present elsewhere in

the Federal Republic and only in a

few places internationally. The

viewpoint that we understand

health to be a central economical

and growth factor, not only a cost

factor, connects us with other

leading regions. We have established

the growth and employment

potential of the regional

health economics in a study, the

central issues of which you can

look up in the chapter on Sphere

of Activity 3 on page 12.”

At the end of 2005, the master plan

for the further development of the

health region was produced.

As a result, the Health Network

Berlin-Brandenburg established

HealthCapital with the aim of

developing and realising the plan.

What goal has top priority?

“Through the resolution of the

master plan by both provincial

governments and the establishment

of the coordinating office,

we have taken a necessary step for

the health region, both as regards

commitment and organisational

form. Health is such an important,

and at the same time such an

exciting subject, that many people

are interested in it. If we succeed in

bundling up the multifarious

activities in the region and further

developing and connecting our

present strengths, a winning model

for all people concerned will result.

Our intention is to bring together

the persons involved who would

perhaps not otherwise come





together and to coordinate the

activities under one roof. Precisely

in the area of health, we have the

opportunity of profitably connecting

the advantages of the metropolis

of Berlin and the province of

Brandenburg. We can provide a

wide range here, ranging from preventive

and curative medicine to

rehabilitation and the wellness

area. This strategic approach is

carried by the provinces politically;

it is developing very positively and

our integrative role is increasingly

perceived and acknowledged.”

What has been done since the

establishment of the network?

“We now wish to reach the point

where the goals presented in the

master plan are actually realised,

piece by piece. The core of our

activities lies in our work in the

twelve spheres of activity. We have

succeeded in finding centrally

responsible people and important

allies in the various areas. Last year

we succeeded in convincing renowned

research institutes, major

clinics, many start-up firms and also

the major firms and players in

Public Health to participate in our

network. The promotion of the

economy, the chamber of commerce

and industry, the health

insurance companies and the AOK

(Germany‘s largest health insurance

company) are in this together

with us. We can already show

definite progress in the individual

spheres of activity. A further

central point is making it clear how

much the individual participants

can profit from each other. Take

the subject of education and

continued education: there are

numerous offerings in the region,

but the coordination leaves something

to be desired. This is exactly

where Sphere of Activity 2 enters

the picture. The labour market is a

centrally important infrastructural

measure: industry based on knowledge,

which we strive for in the

health area, requires well-educated

employees. The first measures in

this area have already been taken.

We have published an education

atlas and installed a portal in the

internet which gives an overview

of the regional educational


Professor Dr. Dr. h.c. Günter Stock,

HealthCapital Network Speaker

What are the next steps?

“The point is to develop concrete

projects and measures, from the

middle- and long-range viewpoint,

and to push ahead with these. We

want to strengthen the integration

of the value chains of earlier

research in marketable products.

We want to increase our presence

at the world‘s health fairs and

better exploit and coordinate

possibilities for the exportation of

the achievements produced here.

We want to keep the region in its

top position – it is already today

the centre of education, continued

education and courses of studies in

the health area – and specifically

strengthen it through new educational

programmes and courses as

well as even more outstanding

professorships at our academies.

We want to make the high-performance

medicine offered by the

special and university clinics useful

for the region through concrete

telemedical applications. Finally,

we want to make the latest knowledge

and applications of molecular

medicine and diagnostics, of regenerative

therapies, early prevention

through in-vitro-diagnostics and

enlightenment accessible to the

citizens of our region and, indeed,

people all over the world. You can

have a glimpse into exemplary

activities of our region on the

following pages.”

What vision do you have for the


“I am convinced that Berlin-

Brandenburg provides the best

prerequisites for becoming the

central health region in Germany

or even for all of Europe. This is

why we wish to convince - more

strongly than before - firms, scientific

institutions and the other

persons involved of the necessity of

this cluster formation. My vision of

the future shows a region pressing

ahead with trailblazing developments

through its wide variety of

innovative projects. It also shows a

region which is equally attractive

for patients, scientists and entrepreneurs.

Not least, I also desire a

region whose citizens assume more

responsibility for their health.”


HealthCapital Berlin-Brandenburg


HealthCapital – the Trademark

of Berlin-Brandenburg

The region possesses a marked

concentration and networking of

science, care and economy which

makes Berlin-Brandenburg one of

the leading health regions in

Europe. Healthy well-being is an

existential component of the

quality of life. At the same time,

the health economy represents a

significant economical factor.

Approximately 350,000 people

work in this area, every eighth

person in the region. With 14

billion Euros gross value added,

they make an essential contribution

to the economical output.

In order to strengthen and expand

this position, the governments of

the provinces of Berlin and

Brandenburg have adopted a

master plan. It comprises 12 spheres

of activity whose commissaries

promote the strengths of the

regional health cluster whilst

continuing to develop the entire

area comprehensively and systematically.

The Network Health

Economy, HealthCapital Berlin-

Brandenburg, was formed for the

practical application.

The Region of Berlin-Brandenburg

Spheres of Activity of the Master Plan, Health Region Berlin-Brandenburg

1. Health sciences as motor of the development

2. Teachings, education, continued education

3. Transparency and control

4. Markets, fairs, congresses

5. Biotechnology and biomedicine

6. Medical technology and telemedicine

7. Offerings and services for the elderly

8. Modernisation and optimisation of health care

9. Prevention, health promotion, rehabilitation and nutrition

10 . Lengthening and strengthening the value chains

11. Health locations and development

12. Export of health and health tourism

Important persons belong to it

from all the areas of health which

make the region so successful.

Among these are those responsible

for education, universities, research

institutions, enterprises in the

areas of pharmacy, biotechnology

and medical technology, hospital

operators and health insurance

companies as well as service providers

and promoting institutions. The

number of partners and members

is constantly growing; any participant

who wishes to become

involved in the network is welcome.

All activities are integrated and

coordinated under the all-encompassing

trademark HealthCapital.

The many-sided approaches aim

towards new products, procedures

and services as well as processes,

forms of organisation and structures.

A special characteristic of the

linking of the regional participants

is the connecting of the metropolis

to the countryside, the city to the

rural areas. The latest medical and

technological developments can be

made accessible to all people with

the help of modern information

systems. A society in which people

live longer and in better health,

and in which the proportion of the

elderly clearly increases, can make

high-performance health care

possible in precisely this manner.

Before the background of a changing

health system and a clear

demographical development, the

region offers outstanding conditions,

not only for assuming a

model role as a pioneer nationwide

but also for setting international



Sphere of Activity 01: Health Sciences as the Basis and Motor of the Development


With its high concentration of

excellent research facilities and

academies, the region of Berlin-

Brandenburg holds a leading position

within Europe. This basis creates

outstanding conditions for economic

growth in all industries motored by

life sciences – whether pharmacy,

biotechnology or medical technology.

Numerous successful substructures

established by academies and

research institutes here also bear

witness to this. However, the technology

transfer from public research

into the economy also functions

better and better without founding

firms. This trend is clearly seen at the

Helmholtz-Zentrum Geesthacht

Institute for Polymer research in

Teltow, which stands for top performance

internationally in the field of

biomaterial development.

New kinds of biomaterials open up

better and, in some cases, not

previously realisable medical possibilities,

especially in the areas of


regenerative medicine and minimally

Creating Products out of Knowledge

invasive surgery. Regenerative

medicine aims towards the healing of

various illnesses through the restoring

of malfunctioning cells, tissues and

organs, both through biological

replacement and through the stimulation

of the body‘s own regenerative

and repairing processes. Minimally

invasive surgery is an operation

technique with very small cuts into

the skin. At the Institute for Polymer

Research, materials with tailor-made

characteristics for specific medical

applications are developed which are,

for example, usable as framework

materials for tissue cultivation or as

implanted materials. “We want to

lead our product candidates to

marketability with industrial partners

starting at a certain degree of development,”

says Institute Director Prof.

Dr. Andreas Lendlein. “We are

creating the necessary conditions for

this in our Institute, for example the

installation of clean rooms and the

provision of production capacities in

“Both things are important for the

strength of our region: excellent fundamental

research and the practical realisation

based upon it in the concrete application.

Each depends on the other.”

order to be able to produce quantities

of material for clinical studies. In

addition, we have established a

quality management system in order

to document our developments

according to the legal regulations.”

Lendlein is also committed to the

realisation of the master plan for the

Berlin-Brandenburg Health Region.

In connection with the health

sciences of the regions, he considers

it important to expand already

existing central concerns and to

continue to optimise the networking.

A special concern of his is the feedback

between science and clinic. “In

addition,” says Lendlein, “we must

continually observe which areas arise

in the fundamental research, so as to

recognise which areas of application

for the future can be derived from

them.” Following such impulses, the

Berlin-Brandenburg Centre for

Regenerative Therapies and the

centre for molecular diagnostics have

been established in the recent years.

Prof. Dr. Andreas Lendlein, Helmholtz-Zentrum

Geesthacht Institute for Polymer research


Sphere of Activity 02: Teachings, Education, Continued Education



Guaranteeing Qualified Specialists for Tomorrow

The field of health economics is

already one of the largest employers

in the region today. Current studies

verify that it is still on the upswing.

This creates new challenges for the

labour market, not only with regard

to the number of specialists but also,

especially, with regard to their

qualification profile. It is necessary

to integrate demographical changes,

rapid medical advances and the

increased interlocking of ambulatory

and stationary care into present and

new educational offerings – extending

from the initial professional

training to the full study programme

to continued education. In Area of

Activity 2 of the master plan for

the Berlin-Brandenburg Health

Region, the participating partners

wish to develop model solutions

which will set a precedent for the

entire nation.

The prerequisite for this is, first of all,

to create clarity concerning the

situation of specialists in the Berlin-

Brandenburg health economics and

their future demands. The IHK Berlin,

BioTOP Berlin-Brandenburg and the

SPI Consult GmbH have asked

enterprises from regional health

economics and persons responsible

for education about this. A result of

the inquiry was that every other

enterprise cannot cover its need for

employees, already today – either

due to the too-low number or the

insufficient qualification profile of

the available personnel. Moreover,

three out of five companies fear that

the present educational contents and

forms no longer correspond to future

needs. This especially applies to the

care and rehabilitation areas.

In order to close this gap and develop

new market-orientated offerings,

Berlin and Brandenburg are planning

increased activities in this area. Dr.

Marion Hass, Director of Innovation

and Environment at the IHK Berlin,

explains present intentions: “We are

now tying up an entire packet of

measures to be taken, comprising

“We are now tying up an entire packet of

measures to be taken, comprising everything

from branch-specific specialist monitoring to a

new arrangement of job descriptions in health

economics to the guaranteeing of specialists

close to businesses.”

everything from branch-specific

specialist monitoring to a new

arrangement of job descriptions in

the health business to the guaranteeing

of specialists close to businesses.

The starting shot for these projects

has been given and joint teams have

been formed.”

A comprehensive educational atlas

for the health field has been published

with the aim of improving the

visibility of the excellent educational

offerings of the health region.

In addition, an online information

portal (

has been installed by HealthCapital

and SPI Consult, with regional

offerings in education and further

education as well as specialised

courses of study. The region will send

out signals to the whole nation with

a fair focussing on the subject of

education in the health business.

Further projects are in the pipeline

which will strengthen Berlin-

Brandenburg in the competition

between German health regions.

Dr. Marion Hass, Director of Innovation and

Environment, IHK Berlin


Sphere of Activity 03: Transparency and Control


Identifying and Exploiting

Growth Potentials

The field of health economics is one

of the largest branches of economics,

both in Berlin-Brandenburg and

in all of Germany. Nonetheless,

there is a lack of valid data which

quantify the growth potentials of

this branch. Until now, this field has

been exclusively registered on the

basis of expenditure categories.

With the study “Growth and

Employment Potentials of Health

Economics in Berlin-Brandenburg,”

added value and employment

effects of health economics were

calculated for the first time for the

region as well as for Germany on

the basis of overall political economic

calculations. Berlin-Brandenburg

is in a good position: a total

gross value added of 14 billion

Euros has been generated through

the entire field which employs

approximately 350,000 people here.

Dr. Dennis Alexander Ostwald and

Dr. Anja Ranscht prepared the study

within the scope of the professorship

Dr. Anja Ranscht,


Technical University


Section model of health economics

Source: Ostwald and Ranscht in reference to the Institute for Labour and Technology, in Hilbert et al, 2002

“The transparency of regional health economics

would be increased with a continuation of

this calculation method; strengths and

weaknesses of individual economic branches

could also be measured in the future with

the help of resilient reference numbers.”

“Health care should be seen as the

industry with the highest impact on

Germanys GNP rather than an expense

factor for the economy.”

of Prof. Dr. h.c. Bert Rürup at

Darmstadt Technical University in

the special field of financial and

economic politics on commission

from HealthCapital Berlin-

Brandenburg. The authors describe

the central renewal in the

method as follows: “Our calculations

are concentrated on the

gross value added generated by

the health economics branch as

well as that in its employees.

These indicators make a considerably

more powerful statement for

economical power of a region or

a special economical branch and

therefore offer more transparency

than previous procedures.”

In the study, health economics is

subdivided into four economical

branches: processing business,

trade, the health field and further

facilities, the latter of which also

includes research and development.

“This approach makes

possible a differentiated consideration

of the individual economical

branches over the past eight

years,” explains Ranscht. “In

addition, we predict continued

development until 2020.”

“The four areas are marked by

different developmental tendencies,”

Ostwald adds. “Berlin-Brandenburg

has an above average situation in

Public Health when compared on a

national basis, for example – meaning

in the areas of stationary and

ambulatory care, rehabilitation and

nursing.” Thus approximately 75 %

of the gross value added of the

entire health branch is made in the

health field in the region. 75% of all

persons earning an income work in

this area as well. “The region will

also profit from this strength in the

future, because Public Health is,

firstly, subjected to fewer globalisation

tendencies and secondly, not as

affected by cutbacks as other areas.”

Altogether, the outstanding competitive

situation of the region is decisively

influenced by the very good

positioning in education, research

and development. “This marked

point of emphasis also attracts

enterprises,” Ranscht believes. The

author team sees further potential in

the growth areas of biotechnology

and medical technology.

Prof. Dr. Bertram Häussler,CEO of IGES Institut

GmbH, one of the leading health research and

consultancy companies in Germany

Growth and Employment Potential of

Health Economics in Berlin-Brandenburg

A Study Commissioned by HealthCapital



Sphere of Activity 04: Markets, Fairs, Congresses



Internationally Attractive Location

Berlin has established itself as a

leading location for fairs and

congresses of health economics.

Ranging from high-grade research

symposia to medical specialists‘

conferences and large fairs and

congresses covering a variety of

subjects, Berlin continues to prove

its international attractiveness as a

place for events, time and again.

An example of this success is the

Capital City Congress for Medicine

and Health, the largest German

congress in this area. Founded ten

years ago, the congress registers

growing numbers of participants

each year. In 2007, approximately

6900 specialist visitors took part.

In 2007, the ITeG – IT Fair & Dialogue

in Public Health, focussing on

information technologies, took place

in Berlin for the first time. In 2008,

the Twentieth International Congress

of Genetics brought scientists from

all over the world into the city and in

2009 the first World Health Summit

“The connection of Berlin top

research and Brandenburg top

technology – precisely in the area of

telemedicine – shows the strengths

of the collaboration in the capital


Dr. Steffen Kammradt

Managing Director of the Brandenburg

Economic Development Board GmbH (ZAB)

“The health economics of the capital

region have a clear strategy and a

trademark. All persons involved – including

politics – are pulling together.”

took place in Berlin. “We are building

on past successes,” says René

Gurka, Managing Director of the

Berlin Partner GmbH. “We continue

to work on bringing more events

from this field to Berlin.”

A further thematic focal point in

Sphere of Activity 4 of the master

plan for the Berlin-Brandenburg

health region concentrates on the

national and international marketing

of the health region. The trademark

HealthCapital” was developed for

this together with Berlin Partner.

“We are presenting the trademark at

fairs at home and abroad, for example

at Arab Health in Dubai and

Medica in Düsseldorf. Of course the

trademark is used at all relevant

activities and it is making its own

appearance on the internet.”

Gurka has established that the

capital region is being increasingly

perceived as a life science region

abroad. “We have an especially

positive image in the USA. There is

definite interest in the Berlin-

Brandenburg health region abroad.

This is strengthened by settlements

such as that of the German head-

René Gurka, Managing Director

Berlin Partner GmbH

quarters of the Pfizer pharmaceutical

concern.” The international networking

with other life science clusters is

also important to him. There is good

contact with the Scandinavian

Medicon Valley, for example. At

present, the cooperation with Mass

MEDIC, the alliance of medical

technological industry in Massachusetts

is being developed.

Berlin-Brandenburg has excellent

advantages of location in the health

area. The international visibility of

the health region is to be strengthened

even more. This is taking place

in close cooperation between the

provinces of Berlin and Brandenburg.

“We have already been

re presented together, both nationally

and internationally, at the most

important fairs over the past several

years, including BIO and Medica,”

Gurka adds. “We will continue to

build on this presence step by step.”

And Dr. Steffen Kammradt, Managing

Director of the Brandenburg

Economic Development Board (ZAB)

adds: “Since January 2007 we also

have a common settlement team

for the life science area, in which

Berlin Partner and ZAB appeal to

investors together and accompany

the settlement.”


Sphere of Activity 05: Biotechnology and Biomedicine



Innovation Motor Biotechnology

The region of Berlin-Brandenburg

has established itself as the leading

European location for biotechnology.

Approximately 190 biotechenterprises

and the resident pharmaceutical

industry profit from the

density and quality of the regional

research facilities and from the

access to the extensive clinic landscape.

Numerous networks concentration

together and encourage

exchanges of knowledge. For over

ten years, BioTOP Berlin-Brandenburg

functions as the central

contact partner for the concerns of

biotechnology and supports enterprises

on the interface between

science and economics.

“Biotechnology comprises a very

broad field today,” says Prof. Dr.

Detlev Ganten, Chairman of the

Board of the Charité Foundation.

“Unlike at the beginning, when one

primarily associated biotechnology

with genome research, biotechnology

today plays a role almost

“We support young founders and

encourage activities that promote the

biotech-scene here.”

Dr. Kai Bindseil, Director

BioTOP Berlin-Brandenburg,

Clustermanager HealthCapital

Prof. Dr. Detlev Ganten,

Chairman of the Board,

Charité Foundation

everywhere in medical research,

whether in cell biology or in

research relating to indication, as

for example with cancer or

coronary-circulatory diseases.” Its

importance in laboratory medicine

and diagnostics also continues

to increase. Here there are

also ever more connections

between biotechnology and

medical technology, for example

in the area of molecular imaging.

“That is why biotechnology has a

fundamental importance at the

Charité for the improvement of

diagnosis and therapy,” Ganten

explains further. “Translational

medicine is especially strengthened,

the realisation of knowledge

gained from fundamental research

in the application.” In academic

facilities, awareness has increased

that not only publications are

important, but also concrete

application. “This transfer takes

place much faster today, and

scientific developments can be

derived from it. We encourage

entrepreneurial thinking and

action at the Charité through the

business area of enterprise development,

through the technology

transfer in the faculty and, since 2005,

through the Charité Foundation. In

this, persons from our successful

substructures bring in their experiences.

Exchanges of ideas are also

encouraged in our cooperation with

the Berlin Biotech discussion table.”

Ganten rates the potential of biotechnology

in Berlin-Brandenburg

very highly and regards the area as

an important growth motor of the

region. “This has also been recognised

by politics. There has been a

very positive development in the past

ten years, and all persons responsible

are pulling together. A long-term

developmental perspective is the

decisive point for a lasting success,

and we are now beginning to reap

the fruits of the investments.” He

desires more long-term approaches

for education in the natural sciences,

because, according to Ganten,

“Scientists are not made at the

university; the interest is born at

kindergarten-age. Nature is the first

thing that drives man onwards in his

curiosity and if one begins more

intensively at this stage, an outstanding

scientific landscape will arise

from this basis.”

“Biotechnology has a fundamental

importance at the Charité for the

improvement of diagnosis and



Sphere of Action 06: Medical Technology and Telemedicine



From the Clinic into the Application

Medical technology is an essential

component of regional health

economics and is considered one of

the most forward-looking areas of

technology in Berlin-Brandenburg.

TSB medici, an initiative of the

Technology Foundation Berlin, has

the task of developing the region

into a supraregional competency

centre of medical technology. The

points of emphasis are the areas of

imaging, oncology, coronary-circulatory

diseases as well as telemedicine

and medical computer sciences.

Numerous innovations from research

and clinic go into the application;

a variety of founded enterprises

out of regional facilities are

convincing through their successful

commercialisation of products all

over the world.

The works of Prof. Dr. Stefan Hesse

show how robots developed in

clinical practice can help stroke

patients to learn to walk again. The

neurologist heads both the Neurol-

Prof. Dr. Stefan Hesse,

Medical Park Berlin Humboldtmühle

Clinic, a state of the art

specialist rehabilitation clinic

ogy Department and the Stroke

Center at the Medical Park Berlin

Humboldtmühle Clinic, which is

specializing in rehabilitation and

follow- up therapy. The Stroke

Center Berlin is unique worldwide.

It ensures a complete chain of

multi-professional rehabilitation

from the Intensive Care Unit up to

home patient care. It is in partnership

with the Charité University

Clinic, and is a member of the

Stroke Alliance (CSB) initiated by

the Neurological Clinic of the

Charité. Prof. Hesse also holds a

lectureship at the Charité Medical

University in Berlin which enables

him to carry on research activities.

His area of specialisation is physical

medicine and rehabilitation of

patients after a stroke, paraplegia

or skull-brain trauma. “We want to

arrive at the point where partially

paralysed stroke patients can

regain their lost motor abilities to

the greatest possible extent. In

achieving this, training is the alpha

and omega. Up until now, this

training was enormously strenuous

for the therapists, who hold,

support and lead the patients. Our

G-EO System has now taken over this

task – a robot developed in cooperation

with the Reha Technology

Bozen, Italy.” The G-EO System is not

the first device created by Hesse‘s

team. Since developing a treadmill

trainer in the early 1990s, the physician,

researcher and entrepreneur

has been developing and distributing

successful products in several countries;

these are used in rehabilitation

for the improvement of walking

ability and arm-hand functions. The

products are manufactured in Berlin

by the firms Wisch Engineering

GmbH and Olioid GmbH. “The

decisive advantage of our new

technological development is that

we try everything out in the clinic

right away,” Hesse emphasises.

“Product developments that do not

pass this practical test are either

discontinued or improved accordingly.”

At present, he wishes to

expand the penetration of the

market. “We want to enter the

American market now. To achieve

this, we have just concluded an

agreement with the Massachusetts

Institute of Technology for the

mutual distribution of our products.”

“The use of robots in rehabilitation

has an enormous future potential.

There is great international interest

in new systems of assistance.”


Sphere of Activity 07: Offerings and Services for the Elderly



Berlin Model of Nursing Is a Nationwide Model

Berlin-Brandenburg is actively

confronting the challenges to

society and politics created by the

demographic transformations. Both

provinces have resolved guidelines

concerning policy for the elderly

and are developing an increasing

number of activities in this area. For

example, the range of offerings for

new, alternative residential formats

for living together at an advanced

age is increasing, in order to do

better justice to differing needs.

These include residential models

for different generations living

together and the installation of

flats and houses in a manner

appropriate for the elderly. At the

end of 2006, the Marseille Clinics

and Berlin‘s Turkish community

opened the first nursing home for

Turks in Berlin Kreuzberg.

Research and science are intensively

occupied with the subject of aging

in a variety of disciplines, for

example in the development of

Just a few changes can make

living easier for the elderly.

Before After

Rolf Dieter Müller, former

Chairman of the Board, AOK Berlin

new technologies. The creation of

a study focussing on aging and

the elderly at Lausitz University of

Applied Sciences indicates the

importance of this subject. The

Berlin Aging Study (BASE, www. has set new

standards in aging research. The

interdisciplinary project of several

research institutions is unique in

the world due to the breadth of

the spectrum of the participating

scientists, the focus on old age

and the empirical relation to a

representative urban population.

The Berlin model nursing project

has not only been running as a

result of very recent discussions,

but already since 1998. At the

centre of this national pioneering

project is a high-quality,

networked local care approach:

the medical care of home residents

by therapists, nurses and

physicians especially placed in

the home. Over two-thirds of the

38 participating homes work with

permanently employed physicians,

and the others cooperate with

medical practices nearby. The

patients are spared unnecessary

stays in hospital and burdensome

transports; home residents are

hospitalised only half as often.

The project, originally decisively

initiated by the AOK Berlin is also

supported by the Physicians‘ Health

Insurance Association Berlin, the

Berlin Hospital Association, the

Union of Private Hospitals, the

Senate administration in charge,

the company health insurances of

the railway and Siemens as well as

the IKK Brandenburg Berlin. “Good

care pays off,” says Rolf Dieter

Müller, former Chairman of the

Board of the AOK Berlin. “Not only

the home residents profit from it,

but the model is also more economical

for health insurance

companies. We register 2.5 to 4

million Euros savings in the homes

participating in the project compared

to other facilities.” The

successful approach which connects

quality and economy has meanwhile

been taken up by the Federal

Ministry of Health, and a legal

anchoring of it is currently under


“Everybody profits from the Berlin

model of nursing: patients, nursing

homes and also health insurance

companies. The fact that we have

gone in the right direction is shown

by the fact that our approach is

now being taken up in the Federal

government‘s care reform.”


Sphere of Activity 08: Modernisation and Optimisation of Health Care



Quality of Patient Care Is Our Top Priority

The German health system is

presently undergoing a dynamic

transformation. A wide variety of

approaches in modernisation and

optimisation of health care go

hand in hand with greater demands

on efficiency. The introduction

of case packages and new

projects of integrated care are

examples of this development.

Modern medical technology and

the use of information technologies

create innovatory thrusts in

health care.

During the past years, several top

performance hospital enterprises

offering high-quality treatments

have established themselves in

Berlin-Brandenburg. In Berlin, the

developments have led to the

urban hospitals in the Vivantes

network being brought together

to form Germany‘s largest communal

hospital concern. Europe‘s

largest university clinic, the Charité

Medical University Berlin, has set

Heidrun Grünewald,

Managing Director of the

Carl Thiem Clinic, Cottbus

up a new structure with 17

expanded centres. The Helios

Clinics, Ltd., one of Europe‘s

leading private hospital chains,

also has its headquarters in Berlin.

With over 1300 beds and almost

2300 employees, the Carl Thiem

Clinic is the largest hospital in

Brandenburg and at the same time

the largest employer in Cottbus.

As a KTQ-qualified health centre of

the region, the clinic stands for

high-performance medicine and,

beyond basic and customary care, is

also equipped for treatment of the

most serious illnesses – for example,

with new operation halls which are

amongst the most modern in

Europe. “Other facilities also

participate in our infrastructure

and medical know-how,” says the

Managing Director of the hospital,

Heidrun Grünewald. “We cooperate

with some of the other hospitals

in the region.” In this connection,

Grünewald rates the new

possibilities of telemedicine extremely

positively. “We are very

well equipped in the area of

telemedicine. Patients from smaller

hospitals, Guben for example, can

be examined by us.” Other hospi-

tals wish to participate and some

local medical practices are already

linked. A pilot project with the

Charité is presently under discussion,

and there have also been initial talks

beyond the border with Poland.

The cooperation with the neighbouring

Sana Heart Centre and the

Brandenburg Technical University

(BTU) Cottbus is especially strong. In

2006 the first year of study in the

Master‘s Degree study programme

in biomedical equipment technology

was created by all three partners

together, and the Human

Ecological Centre of the BTU was

decisively founded in cooperation

with physicians of the Clinic.

Education and qualification is also

emphasised within the hospital

itself. Brandenburg‘s largest medical

school is affiliated with the Carl

Thiem Clinic; it offers several

educational levels in nursing and

the medical-technical area. The

Clinic is the academic teaching

hospital of the Charité “We are

now infusing this cooperation with

life,” says Grünewald. “This also

increases the attraction of our

hospital for the next generation of


“Precisely in a region like Brandenburg,

certain criteria must be

fulfilled in order to guarantee good

health care for the population.

Education and qualification, concentration

and net-working are particularly



Sphere of Activity 09: Prevention, Health Promotion, Rehabilitation and Nutrition



Prevention Is the Best Therapy

The promotion of health and the

prevention of illnesses are increasingly

shifting into the area of

public interest. Berlin and Brandenburg

provide good prerequisites

for making prevention, health

promotion, rehabilitation and

nutrition trademarks of the region.

Nutrition plays an important role

in this. The region occupies an

outstanding position in nutritional

research and is an active force in

the area of nutritional genome

research. This young area of

research unites molecular and

clinical nutritional research, genome

research and plant biotechnology.

A point of emphasis is

genome research and plant biotechnology

in the service of diagnosis,

prevention and treatment of

nutrition-linked illnesses.

One of the main participants in this

area of research is the German

Institute of Human Nutrition (DIfE)

which, in a unique way, connects

“Diabetes Type 2 is a civilisation illness which is on the increase.

Whoever knows his own risk of suffering from Diabetes Type 2

can take countermeasures against it. The AOK Brandenburg

provides information in its magazines for members with the aim

of motivating as many people as possible to undergo the Diabetes

Risk Test developed by the DIfE. It is also possible to take part

in the test via internet, under”

Ulrike Plogstieß, Director of Prevention, AOK Brandenburg

Prof. Dr. med. Dr. rer.nat. Hans-Georg Joost,

Scientific Director, German Institute

of Human Nutrition

clinical, molecular and epidemiological

nutritional research. The

Director of the Institute, Prof. Dr.

Dr. Hans-Georg Joost, is particularly

concerned with the Metabolic

Syndrome and the illnesses

resulting from it, such as diabetes.

“Diabetes Type 2 and the Metabolic

Syndrome are amongst the

greatest Public Health problems

for the next ten to twenty years.”

The DIfE has developed the

German Diabetes Risk Score, an

easily performable test with

which adults can determine their

risk of suffering from Diabetes

Type 2. The test is based on the

data of the wide-ranging Potsdam

EPIC Study (European

Prospective Investigation into

Cancer and Nutrition) with

approximately 27,000 participants.

Persons of 35 years of age upwards

can determine their own

personal risk factors, and then

reduce their influence by changing

their diet and lifestyle – the

test participants receive individually

adjusted recommendations. The test

is available to everyone on the

website of the DIfE (

In addition, the Institute is collaborating

with the AOK Brandenburg

in a model project. The AOK calls

attention to the test in order to

actively promote prevention

amongst its clients by encouraging

them to act responsibly.

Prof. Joost considers the individualisation

of prevention extremely

important: “We want to create the

scientific basis for being able to

offer personally adapted prevention

recommendations. In this

endeavour, genetic parameters will

play an increasingly important role

in the future.” Nutritional habits

are very difficult to change. Scientifically-founded


recommendations are one thing.

The more individualised these are,

the better. Up until now, however,

there has been a lack of data

making a powerful statement as to

how such recommendations are to

be realised in practice as well as

their short-term and long-term

effects. The DIfE would like to carry

out intervention studies making

such an investigation possible.

“We want to create the scientific

basis for being able to

offer personally adapted

prevention recommendations.”


Sphere of Activity 10: Lengthening and Strengthening the Value Chain



Consolidating Clinical Research in the Region

Expanding clinical research and

improving quality standards and

capabilities in this area are considered

high priority all across Germany.

Berlin-Brandenburg is an ideal

location for clinical studies with its

concentration of established clinics

and hospitals – such as Europe‘s

largest university clinic, the Charité

Medical University Berlin and

Germany‘s largest clinic network,

Vivantes. In addition, the metropolitan

area with its diverse population

structure offers best access to

subjects and patients.

The attraction of the location is also

reflected in the establishment and

expansion of contract research

organizations such as PAREXEL

International GmbH, a subsidiary of

PAREXEL International Corporation

with more than 7,000 employees

worldwide. The company is a leading

international service provider for the

pharmaceutical and biotechnology

industry. PAREXEL has had a strong

“PAREXEL shows that the vision

of promoting Berlin as a service

centre of excellence that can

compete on a global scale, has

long become reality.”

presence in Berlin for over 25 years,

supporting the pharmaceutical

industry with its broad range of

knowledge-based contract research

services. Furthermore, PAREXEL

provides services in the area of “drug

development” and “SCOPE – Strategic

Compliance and Operational

Performance Excellence”.

“In Berlin, we benefit from easy

access to medical research facilities

and clinics, a solid infrastructure and

extremely qualified employees

whose reputation is acknowledged

worldwide,” explains Managing

Director Dr. Ulf Schneider. As a result

of these regional advantages, PARE-

XEL has invested considerable

resources: in the training of employees,

the “European Clinical Logistics

Centre,” the Medical Imaging Lab

that utilizes state-of-the-art technologies,

and in the finest equipment

utilized in the clinical-pharmacological

facilities. Furthermore, a new

office building – the third one – is

currently under construction. Today,

more than 1,300 employees work in

Berlin, and that number is likely to

increase due to the company‘s

expected growth.

In addition to its own expansion, the

company is committed to the region

by investing in further areas. In 2001,

Dr. Ulf Schneider,

Managing Director, PAREXEL

International GmbH

PAREXEL established its Academy

which - today - is one of the leading

providers for training, education and

qualification in clinical research

curriculum for the pharmaceutical

industry. The programs are tailored

precisely to current labor market

needs, thus leading to employment

for over 95 % of the graduates.

Given this success experienced over

years, a new vision will be realized:

“In February 2008, PAREXEL Academy

will add a Bachelor of Science

degree (BSc) in Clinical Research –

the first and only one of its kind in

Europe. We are certain that this

unique BSc program is opening up

excellent career opportunities for

the graduates in the fast-pacing,

dynamically growing field of clinical

research, and furthermore contributes

to the development of our

region, not least to its validation by a

British university.“ In addition, the

company is cooperating with Berlin

University of Applied Technical

Sciences in developing the first

European Master program in Clinical

Trial Management.


Sphere of Activity 11: Health Locations and Development


Using the Development

Potential of Health Locations

The health region Berlin-Brandenburg

integrates nearly all subcategories

of “health” – from education

and science to economy and

care. There is an increasing potential

along this value chain for the

founding and growth of enterprises

and the creation of new services.

Health is therefore not only an

important factor in developmental

and structural politics, but also

significant for spatial and urban

development. Berlin and Brandenburg

have recognised the potential

of the multilayered area of health

and, for example, carried on the

development of health-related

technology locations as infrastructural

spatial and urban development.

In both provinces, centres

can be recognised which have the

effect of crystallisation of germcells

for a further expansion.

Take Bad Saarow, for example. This

spa near Berlin has been closely

linked with the subject of health

for approximately 100 years.


Karmen Savor Managing Director, centromed

Berlin-Spandau Betriebs GmbH & Co. KG

The town, set in an attractive

landscape on Lake Scharmützel is

well known for its healing

thermal source and its mineralrich


Another important health

location in the region is Spandau

in the western outskirts of Berlin,

where centrovital, Germanys first

Medical Therapeutic Health

Centre combined with a 4-star

hotel is situated. Health, recreation,

prevention and rehabilitation

are top priorities at centrovital.

“Our motto is relaxing with

style and enjoying healthy” the

Managing Director Karmen Savor

says. Health and wellness is a

recurrent theme throughout the

hotel, from its allergy-friendly

rooms and light life-enhancing

cuisine all the way to the combination

of conventional, natural

and alternative medicines. The

hotel and Health Centre are

connected by a glass bridge,

making them a unique combination

in Europe. Furthermore, with

a steadily growing number of

rehabilitation patients the Health

Centre is an important institution

in Spandau for rehabilitation of

orthopaedic diseases and injuries.

In addition to the orthopaedic

rehab centrovital offers cardiologic

treatment, programmes to lose

weight, physical therapy, dietary

advice, cookery courses as well as

acupuncture. Through cooperations

with hospitals and local

enterprises the hotel is contributing

to the expansion of the tourism

infrastructure, attracting medical

wellness tourists and health-conscious

travellers. centrovital is a

certified member of the German

Medical Wellness Association and

so far the only “Leading Medical

Wellness Hotel” in Berlin.

“centrovital is ideal for guests

who want to combine personalised

health care, therapy,

nutritional advice, wellness

and fitness activities with a

visit to a cosmopolitan city”


Sphere of Activity 12: Export of Health and Health Tourism


Know-How from Berlin-Brandenburg

Is in Demand Worldwide

Berlin has established itself as an

internationally recognised location

for high-performance top-medicine.

Patients come here for treatment

from all over the world. At

the same time, medical products

from Berlin-Brandenburg are in

demand worldwide. A further

potential lies in the export of

specialised services, educational

offerings and system solutions.

The German Heart Centre Berlin

(DHZB) knows very convincingly

how to combine both of these: the

transfer of know-how and the

conquest of a top position in

attractiveness for foreign patients

in this specialised field. For numerous

patients from all over the world,

the Heart Centre is their first choice

of a place to be treated. The 400 to

500 foreign patients per year are

between 8 and 10 percent of all the

patients at the Centre. The reputation

of the German Heart Centre

Berlin is inseparably linked with the


Prof. Dr. med. Dr. h.c. mult. Roland Hetzer,

Medical Director of the German Heart Centre Berlin

renown of its Medical Director, Prof.

Dr. med. Roland Hetzer. The medical

expertise is naturally the main

reason for the reputation. But,

according to Hetzer, “We also want

to offer our foreign patients an

all-round good service. The language

is an integral part of this,

first of all – for example, we have a

website in the Russian and Arabic

languages as first information for

interested persons. It is also important

to be present at international

congresses and fairs and also to

involve oneself with cultural characteristics

– nutrition, help in procuring

a visa, and sometimes such

simple things as a Russian television

programme in the room. In short:

things which have to do with the

function of a hotel.”

Physicians from all over the world

want to acquire the know-how

found here. “We are constantly

providing continued education for

physicians and responding to their

particular wishes,” explains Hetzer.

Some physicians come for only a few

weeks in order to learn certain

operation techniques such as artificial

heart transplantations; others

remain here for up to several years in

order to obtain comprehensive

qualification. There are close connections

to China, for example. But the

physicians do not only come to Berlin.

If circumstances require it, Hetzer

and his team also travel abroad. “A

model example of our commitment

abroad is Sarajevo,” he emphasises.

“The Health Minister of Bosnia-Herzegovina

approached us in 2001 and,

as a result, we have agreed to a

wide-ranging cooperation. One of

our teams travelled to Sarajevo once

a month in order to operate there.

We have given physicians and other

personnel continued education there,

as we have done here. And finally,

we have supported our colleagues in

Sarajevo in building a modern heart

centre.” Continued education is not

only offered for physicians. The

Academy for Cardio-Technology was

set up in 1987 at the DHZB as the

first educational institution of its

kind. Moreover, Prof. Hetzer helped

to found, as an Advisory Board

Member, the new Bachelor Degree

study programme “Physician Assistant”

at the Steinbeis Academy in


“Not only is the medical quality

decisive for international attractiveness

– the service also has to be right.”



Data and Facts about Health Economics

in Berlin-Brandenburg

Important Reference Numbers of Health Economics in Berlin-Brandenburg

Innovative Enterprises

24 pharmaceutical enterprises

190 enterprises in the fields of

biotechnology and biomedicine

200 enterprises in the field of

medical technology

Data Basis: Federal Statistics Office 2006, Provincial Statistics Offices Berlin and Brandenburg 2006, Prognosis 2002, Ostwald and Ranscht.

* GVA = Gross Value Added; LF = Labour Force

Strong Health Economics

Charité Medical University Berlin,

largest university clinic in Europe

Vivantes Network, largest communal

hospital concern in Germany

120 clinics with a total of:

35,000 beds

48 rehabilitation clinics

572 nursing homes and homes for

the elderly

10,000 local physicians

1,400 apothecaries

Quality in Science and Education

Highest density of academies and

research facilities

7 universities, 21 academies and

technical colleges

Over 100 research facilities outside

the universities

15,000 students in 80 health study


35,000 persons being educated in

approximately 60 health professions

Well Advised and Informed

Information on specific subjects

from the health field, economic

promotion and marketing is

available at:


Netzwerk Gesundheitswirtschaft

TSB Innovationsagentur GmbH

Fasanenstraße 85 • 10623 Berlin

Contact: Harald Mylord

Managing Director HealthCapital

Berlin Brandenburg

Telefon +49 30 46302548

Telefax +49 30 46302444

Berlin Partner GmbH

Ludwig Erhard Haus

Fasanenstraße 85 • 10623 Berlin

Contact: Carolin Clement

Teamleiterin Life Sciences

Telefon +49 30 39980230

Telefax +49 30 9980239


Brandenburg GmbH (ZAB)

Steinstraße 104–106

14480 Potsdam

Contact: Dr. Ute Hartmann

Teamleiter Life Sciences

Telefon +49 331 6603838

Telefax +49 331 6603144

BioTOP Berlin-Brandenburg

Fasanenstraße 85 • 10623 Berlin

Contact: Dr. Kai Bindseil, Leiter

Telefon +49 30 31862211

Telefax +49 30 1862222


Fasanenstraße 85 • 10623 Berlin

Contact: Dr. Helmut Kunze, Leiter

Telefon +49 30 46302547

Telefax +49 30 46302444

Gesundheitsstadt Berlin GmbH

Französische Straße 23

10117 Berlin

Telefon +49 30 70011760

Telefax +49 30 700117611

Investitionsbank Berlin

Bundesallee 210

10719 Berlin

Telefon +49 30 21250

Telefax +49 30 21252020

InvestitionsBank des

Landes Brandenburg

Steinstraße 104–106

14480 Potsdam

Telefon +49 331 6600

Telefax +49 331 6601234

Well Advised and Informed






Netzwerk Gesundheitswirtschaft

TSB Innovationsagentur Berlin GmbH

Fasanenstraße 85

10623 Berlin

Telefon +49 30 46 302 548

Telefax +49 30 46 302 444

Concept and Design

Contents / Text

Almut Gebhard, Strategische Kommunikation, Berlin


atelier-Leonhardt (Titel, 3, 4, 5, 7, 9, 10, 11, 12, 17, 19, 23, 30, 31), AOK Berlin (21), Bayer CropScience AG

(16, 17, 24, 25), Bayer HealthCare AG (6, 9, 27), Berlin Partner GmbH (15), BioTOP (16), Carl Thiem Klinikum

Cottbus (22, 23, 26), centrovital (29), HealthCapital (14), centrovital (28, 29), Deutsches Herzzentrum Berlin

(31), Deutsches Institut für Ernährungsforschung (25), (21), GES GmbH (13), Klinikum Barnim

(20), PAREXEL International GmbH (27), Siemens AG (18), ZukunftsAgentur Brandenburg GmbH (14)


500 copies


Europrint medien GmbH, Berlin


This project of the TSB Innovationsagentur Berlin GmbH is subsidised by the Investitionsbank Berlin with

fundings of the Berlin Senate for Economy, Technology an Womens Issues.

More magazines by this user
Similar magazines